Christoph B. Wiedenroth
Christoph B. Wiedenroth publishes mostly in Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Internal Medicine, on topics such as Pulmonary Hypertension Research and Treatments, Venous Thromboembolism Diagnosis and Management and Cardiovascular Function and Risk Factors.
- World rank
- #516,888 of 7,710,434 ranked researchers
- Rank in Germany
- #25,444 of 364,343
- Works
- 120
- Citations
- 2.8k
- Citations per work
- 23.4
What does Christoph B. Wiedenroth research?
Christoph B. Wiedenroth's work is mostly in Medicine (87%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences10486.9%
- Medicine10486.9%
- Everything else1613.1%
- 1Pulmonary and Respiratory Medicine40% of their works
- 2Cardiology and Cardiovascular Medicine27% of their works
- 3Internal Medicine11% of their works
- 4Genetics5% of their works
- 5Surgery2% of their works
- 6Epidemiology2% of their works
Research topics
- Pulmonary Hypertension Research and Treatments
- Venous Thromboembolism Diagnosis and Management
- Cardiovascular Function and Risk Factors
- Cardiac Valve Diseases and Treatments
- Vascular Anomalies and Treatments
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Cardiovascular Issues in Pregnancy
- Heart Failure Treatment and Management
Which keywords describe Christoph B. Wiedenroth's research?
The keywords of their largest research topics: Echocardiography, Pulmonary Hypertension, Right Heart Assessment, Diagnosis, Risk Factors, Treatment, Antithrombotic Therapy and Heart Failure.
- Guidelines
- Pregnancy
- Idiopathic Pulmonary Fibrosis
- Hereditary Hemorrhagic Telangiectasia
- Transcatheter Aortic-Valve Replacement
- Management
- Chamber Quantification
- Heart Failure
- Treatment
- Diagnosis
- Pulmonary Hypertension
- Echocardiography
- Right Heart Assessment
- Risk Factors
- Antithrombotic Therapy
- Venous Thromboembolism
- Diastolic Function
- Surgical Aortic-Valve Replacement
- Genetics
- Fibrosis
- Cardiovascular Diseases
- B-Type Natriuretic Peptide
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Echocardiography1322 topics
- Pulmonary Hypertension1061 topic
- Right Heart Assessment1061 topic
- Diagnosis593 topics
- Risk Factors472 topics
- Treatment462 topics
- Antithrombotic Therapy361 topic
- Heart Failure362 topics
- Venous Thromboembolism361 topic
- Chamber Quantification261 topic
- Diastolic Function261 topic
- Management242 topics
- Surgical Aortic-Valve Replacement151 topic
- Transcatheter Aortic-Valve Replacement151 topic
- Genetics131 topic
- Hereditary Hemorrhagic Telangiectasia131 topic
- Fibrosis121 topic
- Idiopathic Pulmonary Fibrosis121 topic
- Cardiovascular Diseases111 topic
- Pregnancy111 topic
- B-Type Natriuretic Peptide101 topic
- Guidelines101 topic
Where does Christoph B. Wiedenroth work?
Christoph B. Wiedenroth's main affiliation in the publication record is Kerckhoff Klinik, Germany.
How many publications and citations does Christoph B. Wiedenroth have?
OpenAlex counts 120 works and 2,807 citations for Christoph B. Wiedenroth, an h-index of 26, ranking #516,888 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Christoph B. Wiedenroth. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.